NCT00929721已完成不适用
Global Active Surveillance for Community-Acquired Pneumonia (CAP) in Adults 50 Years and Older
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 5,172
- 试验地点
- 1
- 主要终点
- Incidence rates of CAP in adults 50 years and older
研究概览
简要总结
This study is an observational surveillance study to identify adults 50 years and older who present to a study healthcare facility with signs and symptoms of Community-Acquired Pneumonia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult subjects 50 years of age or older
- •Subject must reside in the surveillance area
- •Subjects who present to a study healthcare facility where the treating physician clinically suspects CAP
排除标准
- •Any subject who is transferred to a study healthcare facility after already being hospitalized for 48 hours or more at any other in-patient facility (such as a community hospital).
- •Hospital Acquired pneumonia (ie, develops signs and symptoms of pneumonia after being hospitalized for 48 hours or more).
研究组 & 干预措施
Subjects with Community-Acquired Pneumonia
Other
Subjects with Community-Acquired Pneumonia
干预措施: Blood draw (Procedure)
Subjects with Community-Acquired Pneumonia
Other
Subjects with Community-Acquired Pneumonia
干预措施: Chest X-ray (Procedure)
Subjects with Community-Acquired Pneumonia
Other
Subjects with Community-Acquired Pneumonia
干预措施: urine specimen (Procedure)
Subjects with Community-Acquired Pneumonia
Other
Subjects with Community-Acquired Pneumonia
干预措施: Nasopharyngeal swab (Procedure)
Subjects with Community-Acquired Pneumonia
Other
Subjects with Community-Acquired Pneumonia
干预措施: sputum (Procedure)
结局指标
主要结局
Incidence rates of CAP in adults 50 years and older
时间窗: up to 120 days from enrollment
次要结局
- Frequency of bacterial agents associated with CAP, Case fatality and incidence rates of CAP number and characteristics of subjects from outpatient clinics, emergency rooms, and hospital in-patient departments(up to 120 days from enrollment)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis PatientsCystic FibrosisNCT01375036Gilead Sciences510
撤回
不适用
In-Home Sensor Monitoring of Older Adults With CancerCancerNCT04306783Washington University School of Medicine
招募中
不适用
Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral InfectionsInfluenza, HumanRespiratory Syncytial Virus (RSV)COVID-19Influenza BInfluenza ANCT06207929Evidation Health10,000
Enrolling By Invitation
不适用
Epidemiological Observatory on the Health Conditions of Inpatients Aged 65 or Older at the INRCA Research HospitalsAgingInpatientsNCT01397682Istituto Nazionale di Ricovero e Cura per Anziani2,250
招募中
不适用
A prospective cohort study on active surveillance after neoadjuvant chemoradiation for oesophageal cancer: SANO-2 studycarcinoma of the oesophagusoesophageal cancer1001799010014713NL-OMON52368Erasmus MC, Universitair Medisch Centrum Rotterdam900